Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
228,5 USD | +0,42% | -5,12% | -3,13% |
Grafiek agenda Charles River Laboratories International, Inc.
Komende gebeurtenissen op Charles River Laboratories International, Inc.
Gebeurtenissen op naam
09-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:6181 |
09-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:5467 |
09-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:5315 |
09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4703 |
09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4413 |
09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4224 |
09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4191 |
09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4186 |
09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4182 |
09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:3975 |
08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2841 |
08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2840 |
08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2835 |
08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2714 |
08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2630 |
08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:2053 |
08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:2020 |
08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:1453 |
08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:1335 |
07-04-2024 22:30 | American Association for Cancer Research Meeting |
Geschiedenis van de jaarlijkse publicaties
Start boekjaar | december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 2 621 2 614 0.28% | 2 924 2 891 1.15% | 3 540 3 522 0.52% | 3 976 3 915 1.56% | 4 129 4 107 0.54% | 4 223 |
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | 604 597 1.28% | 701 693 1.26% | 879 878 0.22% | 991 982 0.87% | 1 013 1 017 -0.4% | 1 063 |
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | 497 489 1.64% | 585 575 1.73% | 742 738 0.51% | 834 820 1.67% | 839 842 -0.35% | 877 |
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | 304 284 7.16% | 447 394 13.45% | 481 449 7.01% | 623 568 9.63% | 581 513 13.41% | 552 |
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | 252 240 4.84% | 364 296 23% | 391 358 9.2% | 486 409 18.85% | 475 387 22.66% | 420 |
WPA USD | Gepubliceerd Verwachting Spread | 5,07 4,85 4.57% | 7,20 5,88 22.44% | 7,60 6,99 8.67% | 9,48 7,97 18.98% | 9,22 7,49 23.07% | 8,10 |
Datum van publicatie | 11/02/20 | 17/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | - |
Geschiedenis van de driemaandelijkse publicaties
Start boekjaar | december | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 905 888 1.89% | 914 909 0.58% | 973 995 -2.22% | 989 970 1.93% | 1 100 1 035 6.26% | 1 029 986 4.39% | 1 060 1 054 0.59% | 1 027 1 000 2.61% | 1 013 991 2.24% | 993 | 1 042 | 1 075 | 1 113 | 1 068 |
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | 227 227 -0.22% | 233 233 0.02% | 250 247 1.36% | 240 238 1.14% | 267 260 2.72% | 260 252 3.03% | 260 258 0.62% | 255 241 5.8% | 239 242 -1.38% | 222 | 258 | 283 | 300 | 245 |
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | 189 184 2.52% | 196 194 1.26% | 212 208 1.97% | 201 197 2.26% | 225 213 5.33% | 218 209 3.98% | 216 213 1.41% | 211 194 8.51% | 194 196 -1% | 178 | 212 | 236 | 251 | 203 |
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | 164 135 21.45% | 111 149 -25.64% | 144 142 1.83% | 123 128 -3.67% | 245 155 57.85% | 131 150 -12.47% | 129 143 -10.32% | 113 120 -6.11% | 209 120 74.62% | 96,5 | 130 | 157 | 173 | 145 |
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | 138 109 26.5% | 93,0 109 -14.63% | 109 110 -0.34% | 96,5 98,4 -1.95% | 187 109 71.19% | 103 102 0.7% | 97,0 105 -7.26% | 87,4 88,9 -1.74% | 187 92,4 102.53% | 71,3 | 99,9 | 120 | 132 | 103 |
WPA USD | Gepubliceerd Verwachting Spread | 2,67 2,03 31.32% | 1,81 2,07 -12.39% | 2,13 2,13 -0.04% | 1,88 1,84 2.12% | 3,65 2,14 70.86% | 2,01 1,99 0.87% | 1,89 2,04 -7.23% | 1,69 1,68 0.51% | 3,62 1,78 103.94% | 1,35 | 1,92 | 2,30 | 2,52 | 1,96 |
Datum van publicatie | 16/02/22 | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 11/05/23 | 09/08/23 | 08/11/23 | 14/02/24 | - | - | - | - | - |
Gebeurtenissen in het verleden in de sector Charles River Laboratories International, Inc.
18-04-2024 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Cijferpublicaties |
17-04-2024 08:07 | TELIX PHARMACEUTICALS LIMITED: March 2024 Publicatie van de ontwikkeling van de activiteiten - Activities Report |
10-04-2024 22:10 | PHARVARIS N.V.: Q4 2023 Cijferpublicaties |
10-04-2024 07:22 | POLARIS GROUP: March 2024 Publicatie van de ontwikkeling van de activiteiten |
02-04-2024 08:30 | ABIVAX: Q4 2023 Cijferpublicaties |
01-04-2024 15:00 | BIOMEA FUSION, INC.: Q4 2023 Cijferpublicaties |
29-03-2024 03:42 | ALPHAMAB ONCOLOGY: Q4 2023 Cijferpublicaties |
28-03-2024 21:28 | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Cijferpublicaties |
28-03-2024 21:05 | ARRIVENT BIOPHARMA, INC.: Q4 2023 Cijferpublicaties |
28-03-2024 12:10 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Cijferpublicaties |